Biopharmaceutical research companies are conducting or have conducted nearly 500 clinical trials of new medicines in Southeastern North Carolina since 1999 in collaboration with clinical research centers and hospitals. Southeastern North Carolina consists of nine counties, including: Bladen, Brunswick, Columbus, Cumberland, New Hanover, Onslow, Pender, Robeson and Sampson.
Of the nearly 500 clinical trials, 203 have targeted the nation’s six most debilitating chronic diseases—asthma, cancer, diabetes, heart disease, mental illness and stroke.
“Though I recognize the positive impact clinical research has on our economy, I am focused more on patients. And it’s important biopharmaceutical companies alone have conducted 500 trials in Southeast North Carolina, with more to come, giving chronic disease sufferers and others who want to participate in trials ample opportunities. For some patients, a trial of a new medicine can be a good therapeutic alternative to discuss with health care providers and clinicians conducting trials. Patients participating in clinical research take an active role in managing their health care, and are contributing to scientific knowledge that could ultimately help treat many other patients.” --Kay Castillo, Director of Advocacy, Policy, and Legislation, National Association of Social Workers of North Carolina